Thryvv : ratio page

Orchid Pharma

Overview Articles News Financials Ratios Shareholding Peers

Financial Ratios

View
Order
Financial Ratios
Mar2024
Mar2023
Mar2022
Mar2021
Mar2020
Valuation Parameters:
PE(x)
57.52
33.87
0.00
0.00
0.00
PCE(x)
41.32
14.26
38.52
736.19
0.00
Price/Book(x)
4.53
2.28
1.79
15.41
0.00
EV/Net Sales(x)
6.31
2.81
2.54
23.32
0.90
EV/Core EBITDA(x)
36.42
18.03
22.34
159.31
7.95
EV/EBIT(x)
47.56
21.21
-60.59
-243.82
-6.83
EV/CE(x)
3.96
1.83
1.55
9.49
0.33
MCap / Sales
6.47
2.36
2.07
22.36
0.00
Growth Ratio:
Net Sales Growth(%)
23.05
19.00
24.33
-6.97
-19.36
Core EBITDA Growth(%)
36.82
63.14
-3.48
20.95
965.63
EBIT Growth(%)
23.29
476.02
45.54
32.18
-183.40
PAT Growth(%)
72.07
197.10
40.26
-36.67
-200.41
EPS Growth(%)
60.13
2474.06
98.33
11.09
-511.60
Financial Stability Ratios:
Total Debt/Equity(x)
0.12
0.48
0.41
0.69
0.74
Current Ratio(x)
3.04
1.35
1.60
3.02
3.25
Quick Ratio(x)
2.03
0.73
0.88
1.94
2.44
Interest Cover(x)
6.49
2.68
-0.70
-0.82
-10.19
Operational & Financial Ratios:
Earnings Per Share (Rs)
18.17
11.35
-0.48
-28.55
-32.11
CEPS(Rs)
25.30
26.96
7.38
3.35
11.82
DPS(Rs)
0.00
0.00
0.00
0.00
0.00
Book NAV/Share(Rs)
230.58
168.72
158.61
159.96
187.67
Tax Rate(%)
-3.39
0.00
0.00
0.00
0.00
Margin Ratios:
Core EBITDA Margin(%)
13.52
12.66
9.75
11.26
6.24
EBIT Margin(%)
13.26
13.24
-4.19
-9.56
-13.12
Pre Tax Margin(%)
11.22
8.30
-10.17
-21.16
-14.41
PAT Margin (%)
11.60
8.30
-10.17
-21.16
-14.41
Cash Profit Margin (%)
15.66
16.52
5.38
3.04
9.97
Performance Ratios:
ROA(%)
6.84
4.73
-4.85
-7.06
-3.07
ROE(%)
10.23
8.27
-8.75
-13.43
-225.00
ROCE(%)
9.35
9.11
-2.32
-3.53
-3.29
Asset Turnover(x)
0.59
0.57
0.48
0.33
0.21
Sales/Fixed Asset(x)
0.65
0.56
0.48
0.37
0.35
Working Capital/Sales(x)
1.54
5.16
3.90
1.57
1.23
Efficiency Ratios:
Fixed Capital/Sales(x)
1.54
1.80
2.10
2.69
2.86
Receivable days
91.49
105.72
99.89
82.59
70.86
Inventory Days
109.80
110.01
106.18
119.45
117.49
Payable days
152.17
162.30
161.59
168.95
362.60